Eligibility for recombinant tissue plasminogen activator treatment
| Valid cases (n) | Patients fulfillinginclusion (n) | % (95% CI) | |
|---|---|---|---|
| DBP, diastolic blood pressure; INR, international normalised ratio; NIHSS, National Institute of Health Stroke Scale; SBP, systolic blood pressure | |||
| Admission <2 h of symptom onset | 733 | 135 | 18.4 (15.8 to 21.4) |
| Age <80 years | 737 | 523 | 71 (67.6 to 74.1) |
| NIHSS Score 4–23 | 740 | 410 | 55.4 (51.8 to 58.9) |
| INR <1.6 | 637 | 612 | 96.1 (94.3 to 97.3) |
| Platelet count >100 000/mm3 | 732 | 724 | 98.9 (97.9 to 99.4) |
| Glycaemia 50–400 mg | 703 | 699 | 99.4 (98.5 to 99.8) |
| No seizures at onset | 725 | 706 | 97.4 (95.9 to 98.3) |
| SBP <185 mm Hg | 743 | 648 | 87.2 (84.6 to 89.4) |
| DBP <110 mm Hg | 743 | 667 | 89.8 (87.4 to 91.7) |
| All criteria fulfilled | 745 | 53 | 7.1 (5.5 to 9.2) |